Mechanisms of myeloma growth in bone marrow microenvironment and development of novel therapeutic options for myeloma
Mechanisms of myeloma growth in bone marrow microenvironment and development of novel therapeutic options for myeloma
批准号:
26461422
负责人:
ABE Masahiro
金额:
$3.08万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2014
资助国家:
日本
项目状态:
已结题
起止时间:
2014-04-01 至 2017-03-31
中文摘要
点击翻译按钮获取中文摘要
英文摘要
期刊论文(7)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
DOI:
10.18632/oncotarget.11927
发表时间:
2016-10-25
期刊:
Oncotarget
影响因子:
--
作者:
[Amachi R, Hiasa M, Teramachi J, Harada T, Oda A, Nakamura S, Hanson D, Watanabe K, Fujii S, Miki H, Kagawa K, Iwasa M, Endo I, Kondo T, Yoshida S, Aihara KI, Kurahashi K, Kuroda Y, Horikawa H, Tanaka E, Matsumoto T, Abe M]
通讯作者:
Abe M
Expansion of Th1-like Vγ9Vδ2T cells by new generation IMiDs, lenalidomide and pomalidomide, in combination with zoledronic acid.
通过新一代 IMiD、来那度胺和泊马度胺与唑来膦酸联合扩增 Th1 样 Vγ9Vδ2T 细胞。
DOI:
10.1038/leu.2016.273
发表时间:
2017
期刊:
Leukemia
影响因子:
11.4
作者:
[2. Harada T, Miki H, Cui Q, Oda A, Amachi R, Teramachi J, Bat-Erdene A, Sogabe K, Iwasa M, Fujii S, Nakamura S, Kagawa K, Yoshida S, Endo I, Aihara K, Ozaki S, Matsumoto T, Abe M.]
通讯作者:
Abe M.
DOI:
10.1038/leu.2014.147
发表时间:
2015-01-01
期刊:
LEUKEMIA
影响因子:
11.4
作者:
[Hiasa, M., Teramachi, J., Abe, M.]
通讯作者:
Abe, M.
Susceptibility to bendamustine considerably varies among myeloma cells, but is enhanced in acidic conditions
骨髓瘤细胞对苯达莫司汀的敏感性差异很大,但在酸性条件下增强
DOI:
--
发表时间:
2016
期刊:
International Journal of Myeloma
影响因子:
--
作者:
[Shingen NAKAMURA , Hirokazu MIKI , Asuka ODA , Ryota AMACHI , Jumpei TERAMACHI , Kimiko SOGABE , Hikaru FUJINO , Tomoko MARUHASHI , Shiro FUJII , Kumiko KAGAWA and Masahiro ABE]
通讯作者:
Kumiko KAGAWA and Masahiro ABE
Induction of endoplasmic reticulum stress by bortezomib sensitizes myeloma cells to DR5-mediated cell death
硼替佐米诱导内质网应激使骨髓瘤细胞对 DR5 介导的细胞死亡敏感
DOI:
--
发表时间:
2015
期刊:
International Journal of Myeloma
影响因子:
--
作者:
[Miki H, Nakamura S, Oda A, Amachi R, Watanabe K, Hanson D, Teramachi J, Hiasa M, Yagi H, Sogabe K, Takahashi M, Maruhashi T, Udaka K, Harada T, Fujii S, Nakano A, Kagawa K, Ri M, Iida S, Ozaki S, Matsumoto T, Abe M]
通讯作者:
Abe M
The roles of the TAK1-Pim-2 pathway in drug resistance and bone destruction in multiple myeloma and development of novel agents to conquer them
-
批准号:18K08329
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.66万
-
财政年份:2018
-
负责人:ABE Masahiro
-
依托单位:
Mechanisms of bone destruction and drug resistance in myeloma: a novel therapeutic strategy targeting a myeloma-bone marrow interaction
-
批准号:23591390
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$3.24万
-
财政年份:2011
-
负责人:ABE Masahiro
-
依托单位:
The Effect of Gender Equality Policy on the Labor Market in Japan
-
批准号:20330051
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$9.15万
-
财政年份:2008
-
负责人:ABE Masahiro
-
依托单位:
Identification and clinical application of osteoclast-derived growth factors for myeloma
-
批准号:15591010
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.24万
-
财政年份:2003
-
负责人:ABE Masahiro
-
依托单位:
Roles for MIP-1α and β in the development of osteolytic lesions in multiple myeloma
-
批准号:13671067
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$0.9万
-
财政年份:2001
-
负责人:ABE Masahiro
-
依托单位:
海外基金